ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Decreased CDKL2 Expression in Clear Cell Renal Cell Carcinoma Predicts Worse Overall Survival

Chen, Zhan; Lv, Yan; He, Lu; Wu, Shunli; Wu, Zhuang*wuhan univ sci & technol
Frontiers in Molecular Biosciences2022-1-13DOI: 10.3389/fmolb.2021.657672
2被引7阅读
引用收藏
分享

摘要

Background: Clear cell renal cell carcinoma (ccRCC) is the most frequent and lethal type of kidney cancer. Although differential expression of cyclin-dependent kinase-like 2 (CDKL2) has been reported to be associated with tumor progression in other cancers, its prognostic value, and potential mechanism in patients with ccRCC still remain unknown.Methods: Gene expression analysis was conducted using The Cancer Genome Atlas (TCGA), Gene Expression Omnibus, and International Cancer Genome Consortium databases. Further, clinicopathologic analysis; Kaplan-Meier survival analysis; weighted gene co-expression network analysis; gene set enrichment analysis; gene ontology enrichment; methylation; and immune infiltration analyses were performed using TCGA-kidney renal clear cell carcinoma profiles. CDKL2 translational levels were analyzed using The Human Protein Atlas database.Results: CDKL2 expression was decreased in ccRCC samples retrieved from the four databases. Gender, survival status, histologic grade, clinical stage, TNM classification, and tumor status were closely related to CDKL2 expression. In addition, CDKL2 downregulation was an independent prognostic factor for poor prognosis in multivariate analysis. Enrichment analyses using multiple tests revealed that CDKL2 is not just closely related to immune response but this association is highly correlated as well. Further, we found that CDKL2 expression was significantly correlated with the infiltration levels of T cell CD4 memory resting; monocytes; macrophages M0, M1, and M2; dendritic cells resting; mast cells resting; plasma cells; T cell CD8; and T cell regulatory.Conclusion: This is the first report to study the expression of CDKL2 in ccRCC, wherein we suggest that decreased CDKL2 expression is closely correlated with poor prognosis in ccRCC. We consider that CDKL2 is a novel and potential prognostic biomarker associated with immune infiltrates in ccRCC.

学科与关键词

关键词
Cdkl2clear cell renal cell carcinomaimmune infiltratesbiomarkeroverall survival
相关
加载中…
  • miR-21-5p/PRKCE axis implicated in immune infiltration and poor prognosis of kidney renal clear cell carcinoma
    Wang, Jinxiang; Jin, Jie; Liang, Yanling; Zhang, Yihe; Wu, Nisha; Fan, Mingming; Zeng, Fangyin*; Deng, Fan*Frontiers in Genetics, 2022, 13: 978840.
  • Identification of MICALL2 as a Novel Prognostic Biomarker Correlating with Inflammation and T Cell Exhaustion of Kidney Renal Clear Cell Carcinoma
    Lin, Wenfeng; Chen, Wenwei; Zhong, Jisheng; Ueki, Hideo; Xu, Abai; Watanabe, Masami; Araki, Motoo; Liu, Chunxiao; Nasu, Yasutomo; Huang, Peng*American Journal of Cancer Research, 2022, 13(3): 1214-1228.被引 2
  • The CSRNP Gene Family Serves as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma
    Zhang, Huaru; Qiu, Xiaofu; Yang, Guosheng*Frontiers in Oncology, 2021, 11: 620126.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Molecular Biosciences
发表日期
2022-01-13
卷期
第 8 卷
页码
657672
DOI
10.3389/fmolb.2021.657672
期刊等级
3区
成果收录
SCIE

作者

  • C

    Chen, Zhan (第一作者)

    wuhan univ sci & technol

  • L

    Lv, Yan

    wuhan univ sci & technol

查看全部 5 位作者收起作者
  • H

    He, Lu

    wuhan univ sci & technol

  • W

    Wu, Shunli

    wuhan univ sci & technol

  • W

    Wu, Zhuang (通讯)

    wuhan univ sci & technol

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417